synonyms ALK+ ALKpos ALK+ve ALK(+) ALK-(+) ALK-Positive ALK Positive Expressing ALK Positive for ALK Expression of ALK ALK Positive by IHC ALK tyrosine kinase receptor Expression Positive
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) 155 sites for NCT03178552 ALK Alternative Transcription Site, +7 more biomarkers Non-Small Cell Lung Carcinoma alectinib, +2 more drugs immunotherapy, +1 more type
Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma 71 sites for NCT03570892 ALK Alternative Transcription Site, +7 more biomarkers ALK-Positive Large B-Cell Lymphoma, +13 more conditions chemotherapy, +1 more drug cellular therapy, +2 more types
A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory PTCL 1 site for NCT05138458 ALK Alternative Transcription Site, +5 more biomarkers Anaplastic Large Cell Lymphoma, +4 more conditions lymphodepletion therapy, +1 more drug chemotherapy, +2 more types
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy 35 sites for NCT04591431 AKT1 Amplification, +59 more biomarkers Malignant Solid Tumor ado-trastuzumab emtansine, +19 more drugs immunotherapy, +1 more type
Auto Stem Cell Transplant for Lymphoma Patients 1 site for NCT03125642 ALK Alternative Transcription Site, +4 more biomarkers Anaplastic Large Cell Lymphoma, +11 more conditions autologous hematopoietic stem cell transplantation, +6 more drugs cellular therapy, +2 more types
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma 1 site for NCT04002947 ALK Expression, +4 more biomarkers ALK-Positive Large B-Cell Lymphoma, +8 more conditions acalabrutinib, +2 more drugs chemotherapy, +1 more type
crizotinib ALK Expression, +19 more biomarkers Systemic Anaplastic Large Cell Lymphoma Relapse/refractory crizotinib targeted therapy
alectinib ALK Expression, +19 more biomarkers Systemic Anaplastic Large Cell Lymphoma Subsequent line alectinib targeted therapy
crizotinib ALK Expression, +19 more biomarkers Systemic Anaplastic Large Cell Lymphoma Subsequent line crizotinib targeted therapy
Cancer Search
